MRNA Archives - BioPharmaJournal

Flora Growth Corp (NASDAQ:FLGC) intends to explore a preventative application against...

Matt Wade - February 9, 2022 0

Covid Stocks Could Represent Huge Value on Sale (NVAX, OTLC, PFE,...

Matt Wade - January 21, 2022 0

Why 2022 Could Open Gangbusters for Covid Stocks (AZN, OTLC, NVAX,...

Kate Hudson - December 31, 2021 0

Moderna Inc. (NASDAQ: MRNA) Announce Phase 2 EPICCURE Study Results Evaluating...

Kate Hudson - November 30, 2021 0

Approval Moderna Inc.’s (NASDAQ: MRNA) COVID-19 Vaccine In Teenagers Delayed Because...

Gavins Felicity - October 22, 2021 0

Moderna Inc.’s (NASDAQ: MRNA) COVID-19 Vaccine Booster Under EU Review

Gavins Felicity - October 6, 2021 0

Indian Government Will Not Purchase the Pfizer Inc. (NYSE: PFE) and...

Gavins Felicity - September 27, 2021 0

Moderna Inc. (NASDAQ: MRNA) Receives New Drug Submission Approval From Health...

Gavins Felicity - September 20, 2021 0

Moderna (NASDAQ: MRNA) Reveals Plans to Create A Combined Coronavirus and...

Kate Hudson - September 13, 2021 0

Moderna (NASDAQ: MRNA) Receives Emergency Use Authorization For Its COVID-19 Vaccine...

Gavins Felicity - September 6, 2021 0

12 3 Page 1 of 3

CymaBay Therapeutics Inc (NASDAQ: CBAY) Announces Promising Seladelpar Data In Treatment...

Gavins Felicity - July 5, 2022 0

CymaBay Therapeutics Inc (NASDAQ: CBAY) has announced the presentation of promising seladelpar findings in primary biliary cholangitis (PBC) patients at The International Liver Congress...

Chimerix Inc (NASDAQ: CMRX) Receives $25.3 Million Procurement Contract For TEMBEXA

July 4, 2022

Regulus Therapeutics Inc (NASDAQ: RGLS) Pleased after FDA Approved its Orphan...

July 1, 2022

Cannabis Stocks Deeply Oversold with Big Growth Ahead (TLRY, SGMD, OGI,...

June 30, 2022

Ocugen Inc (NASDAQ: OCGN) Announces the Successful Publication of Positive Outcomes...

June 30, 2022

Tag: MRNA

Recent Post